spacer
home > ict > spring 2008 > sound starts
PUBLICATIONS
International Clinical Trials

Sound Starts

Relationships built on trust, expertise and effective management tools pave the path for clinical trial success, contend Frank Dunn and Jeffery Bowden of Biomedical Systems

Clinical trials are endeavours of discovery. The questions that must be answered range from the mundane, such as logistics, to core questions about the safety and efficacy of a particular drug or medical device. Experience, sound relationships and effective tools carry those involved in the execution of clinical trials through the myriad of pitfalls and peaks to a successful conclusion of the study.

The seeds for the success of a trial, and ultimately clean study data, are sown in the beginning stages of the process. Study issues, for example shifting timelines, are inherent to trials and can only be resolved with clinical trial experience, process/product development and excellent communication between sponsors and the imaging core lab.

GOOD PROJECT MANAGEMENT IS ESSENTIAL TO STUDY SUCCESS

The transition from the initial contracting phase of a relationship between sponsor and lab to the start-up of the trial can sometimes be a volatile period, especially if the two have not worked together. The sponsor is anxious to be moving forward and may be a little apprehensive about placing their trust in someone new to the process. In this environment, it is important that the project managers (PM) quickly establish their credentials, develop a relationship, and understand the expectations of the sponsor and clinical team.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Frank Dunn is Medical Writer, Imaging Services, at Biomedical Systems. Frank joined the company in 2006 following 22 years of Federal Government service. Prior to joining Biomedical Systems, Frank served as a Public Affairs Specialist with the US Coast Guard. His extensive experience in developing written documents that explain technical details on topics ranging from search and rescue cases to large pollution incident, natural disasters and terrorist attacks, have prepared him for the challenge of medical writing.

Jeffery J Bowden is President, Imaging Services, at Biomedical Systems. Jesse joined the company in 2004 as Vice President of Imaging Services. Prior to that, he was Assistant Director of Clinical and Regulatory Affairs with Tyco Healthcare, Mallinckrodt and Director of Applications Development for Intelligent Imaging. He also created and managed the in-house imaging core laboratory instrumental in supporting the Imaging Clinical Trials for Nycomed, Inc (which is now a part of GE Healthcare). Jesse has created and managed four imaging core laboratories from their inception and has participated in over 150 clinical trials. He has developed numerous proprietary applications designed for the collection, analysis and storage of clinical data acquired during clinical trials.

spacer
Frank Dunn
spacer
spacer
spacer
Jeffery J Bowden
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Switzerland overtakes Germany as Europe’s biggest drug delivery innovator, with the UK and France close behind

Paris, 19th August 2019: As predicted by the ‘European drug delivery and packaging’ report earlier this year, new data shows innovation in drug delivery is accelerating across Europe – with provisional findings from the Pharmapack Innovation Index (2020) showing that Switzerland has over taken Germany as Europe’s most innovative drug delivery market.
More info >>

White Papers

Accelerate Your Database Lock Using Clean Patient Optics

Bioclinica

Because a key step towards database lock is obtaining clean data for all patients, the ability to verify that data are clean early accelerates the ability to lock the clinical database. This ultimately shortens the overall study timeline while ensuring the quality of your data. However, this can be challenging when manually reviewing study data, particularly with larger studies.
More info >>

 
Industry Events

ESMO Targeted Anticancer Therapies Congress 2020

2-4 March 2020, Paris, France

A unique and international mix of experts, researchers and decision makers both from academia and industry across the globe, will convene in Paris for a three-day Congress aiming at exchanging knowledge, experience and research innovations in cancer. TAT 2020 will focus, among others, on novel strategies in immuno-oncology, personalised medicine and molecular tumour boards, preclinical studies to identify effective combination therapies, use of microbiome, tumour agnostic trials, ADC technology, oncolytics, multispecific biological constructs and targeting cytokines. Participating in TAT 2020 will offer you the possibility to take part in interdisciplinary discussions inspiring new ideas and new collaborations.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement